Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
305.00 x 1 333.00 x 3
Pre-market by (Cboe BZX)
319.93 +11.14 (+3.61%) 04/24/25 [NASDAQ]
305.00 x 1 333.00 x 3
Pre-market 319.93 unch (unch) 16:00 ET
Profile for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Madrigal Pharmaceuticals Inc 200 BARR HARBOR DRIVE SUITE 200 WEST CONSHOHOCKEN PA 19428 USA

www.madrigalpharma.com Employees: 528 P: 267-824-2827

Sector:

Medical

Description:

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-' agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 7,064,051
Enterprise Value, $K 7,076,601
Shares Outstanding, K 22,080
Annual Sales, $ 180,130 K
Annual Net Income, $ -465,890 K
Last Quarter Sales, $ 103,320 K
Last Quarter Net Income, $ -59,420 K
EBIT, $ -497,880 K
EBITDA, $ -495,090 K
60-Month Beta -0.69
% of Insider Shareholders 22.80%
% of Institutional Shareholders 98.50%
Float, K 17,046
% Float 77.20%
Short Volume Ratio 0.73

Growth:

1-Year Return 56.33%
3-Year Return 357.04%
5-Year Return 287.89%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -301.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.71 on 02/26/25
Next Earnings Date 05/01/25 [BMO]
Earnings Per Share ttm -22.11
EPS Growth vs. Prev Qtr 44.92%
EPS Growth vs. Prev Year 52.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 07/25/16

MDGL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.53%
Return-on-Assets % -43.36%
Profit Margin % -258.64%
Debt/Equity 0.16
Price/Sales 37.85
Price/Cash Flow N/A
Price/Book 8.75
Book Value/Share 34.59
Interest Coverage -30.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective